JP Morgan analyst Tycho Peterson initiates coverage on Singular Genomics Systems (NASDAQ:OMIC) with a Overweight rating and announces Price Target of $30.
JP Morgan analyst Anupam Rama initiates coverage on Day One Biopharmaceutical (NASDAQ:DAWN) with a Overweight rating and announces Price Target of $38.